We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Bausch Health Companies Inc (BHC) NPV

Sell:$8.32 Buy:$8.33 Change: $0.05 (0.60%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$8.32
Buy:$8.33
Change: $0.05 (0.60%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Sell:$8.32
Buy:$8.33
Change: $0.05 (0.60%)
Market closed |  Prices as at close on 4 October 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures and markets, primarily in the therapeutic areas of gastroenterology (GI), hepatology, neurology and dermatology, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the United States and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products, and other products. Its Solta Medical segment consists of global sales of Solta Medical aesthetic medical devices. Its Diversified segment consists of sales in the United States of pharmaceutical products in the areas of neurology and certain other therapeutic classes. Its Bausch + Lomb segment consists of global sales of Bausch + Lomb Vision Care, surgical and pharmaceutical products.

Contact details

Address:
2150 St. Elzear Blvd. West, Laval
LAVAL
H7L 4A8
Canada
Telephone:
+1 (514) 7446792
Website:
https://www.bauschhealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BHC
ISIN:
CA0717341071
Market cap:
$2.95 billion
Shares in issue:
361.33 million
Sector:
Pharmaceuticals
Exchange:
New York Stock Exchange
Country:
Canada
Currency:
US dollar
Indices:
n/a

Key personnel

  • Thomas Appio
    Chief Executive Officer, Director
  • Jean-Jacques Charhon
    Chief Financial Officer, Executive Vice President
  • Seana-Lyn Carson
    Executive Vice President, General Counsel
  • John Barresi
    Senior Vice President, Chief Accounting Officer, Controller

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.